Share This Author
A species difference in the presystemic metabolism of carbazeran in dog and man.
- B. Kaye, J. Offerman, J. Reid, H. Elliott, W. Hillis
- BiologyXenobiotica; the fate of foreign compounds in…
- 1 December 1984
TLDR
Clinical Pharmacokinetics of Amlodipine
- P. Meredith, H. Elliott
- Biology, MedicineClinical pharmacokinetics
- 1992
TLDR
ACE (I/D) genotype as a predictor of the magnitude and duration of the response to an ACE inhibitor drug (enalaprilat) in humans.
- S. Ueda, P. Meredith, J. Morton, J. Connell, H. Elliott
- MedicineCirculation
- 17 November 1998
TLDR
Inhibitory effect of uraemia on the hepatic clearance and metabolism of nicardipine.
- J. Ahmed, A. Grant, R. Rodger, G. R. Murray, H. Elliott
- Medicine, BiologyBritish journal of clinical pharmacology
- 1 July 1991
TLDR
Effects of prostaglandins, theophylline, and cholera exotoxin upon transmucosal water and electrolyte movement in the canine jejunum.
- N. Pierce, C. Carpenter, H. Elliott, W. Greenough
- Medicine, BiologyGastroenterology
- 1971
Doxazosin, an alpha 1-adrenoceptor antagonist: pharmacokinetics and concentration-effect relationships in man.
- J. Vincent, H. Elliott, P. Meredith, J. Reid
- Medicine, BiologyBritish journal of clinical pharmacology
- 1 June 1983
TLDR
Enalapril Clinical Pharmacokinetics and Pharmacokinetic-Pharmacodynamic Relationships
- R. Macfadyen, P. Meredith, H. Elliott
- Medicine, BiologyClinical pharmacokinetics
- 1 October 1993
TLDR
White-coat hypertension as a cause of cardiovascular dysfunction
- S. Glen, H. Elliott, J. Curzio, K. Lees, J. Reid
- MedicineThe Lancet
- 7 September 1996
A pharmacodynamic and pharmacokinetic assessment of a new alpha-adrenoceptor antagonist, doxazosin (UK33274) in normotensive subjects.
- H. Elliott, P. Meredith, D. Sumner, K. McLean, J. Reid
- Medicine, BiologyBritish journal of clinical pharmacology
- 1 May 1982
TLDR
How reproducible is bilateral forearm plethysmography?
- J. Petrie, S. Ueda, A. Morris, L. Murray, H. Elliott, J. Connell
- Medicine, BiologyBritish journal of clinical pharmacology
- 1 February 1998
TLDR
...
...